[IF=9.6]Targeting the ARRDC3–DRP1 Axis via hUMSC‐Derived Exosomal CRYAB for Neuroprotection in Cerebral Ischemia/Reperfusion Injury Adv Healthc Mater. 2026 Jan 19;15(14):e03803
发布日期：2026/4/21 13:22:34
作者：Rong ji 1, Zengyu Zhang 1, Zhuohang Liu 2, Kaicheng Yang 1, Xueyu Mao 1, Min Chu 3, Yong Wang 4,✉, J
科研单位：1 Department of Neurology, Minhang Hospital, Fudan University, Shanghai, China 2 Department of Rehab
期刊：Advanced Healthcare Materials
DOI：10.1002/adhm.202503803
影响因子:9.6
引用产品:[FS1157] CCK-8细胞增殖及毒性检测试剂
科研单位：1 Department of Neurology, Minhang Hospital, Fudan University, Shanghai, China 2 Department of Rehab
期刊：Advanced Healthcare Materials
DOI：10.1002/adhm.202503803
影响因子:9.6
引用产品:[FS1157] CCK-8细胞增殖及毒性检测试剂
上一篇：[IF=8.9]Hypoxia-preconditioning human bone marrow-derived mesenchymal stem cells induce high-quality mitochondrial transfer through gap junctions to alleviate ischemiareperfusion injury in liver graft-17 October 2025
下一篇：[IF=13.2]Reprogramming emergent metabolism by engineering viable and functional fungal SynCom for bioaugmentation Chemical Engineering Journal Volume 527, 1 January 2026, 172038
下一篇：[IF=13.2]Reprogramming emergent metabolism by engineering viable and functional fungal SynCom for bioaugmentation Chemical Engineering Journal Volume 527, 1 January 2026, 172038
.jpg)
